Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
2005-12-2
pubmed:abstractText
Despite a clear link between ataxia-telangiectasia mutated (ATM)-dependent phosphorylation of p53 and cell cycle checkpoint control, the intracellular biology and subcellular localization of p53 phosphoforms during the initial sensing of DNA damage is poorly understood. Using G0-G1 confluent primary human diploid fibroblast cultures, we show that endogenous p53, phosphorylated at Ser15 (p53Ser15), accumulates as discrete, dose-dependent and chromatin-bound foci within 30 minutes following induction of DNA breaks or DNA base damage. This biologically distinct subpool of p53Ser15 is ATM dependent and resistant to 26S-proteasomal degradation. p53Ser15 colocalizes and coimmunoprecipitates with gamma-H2AX with kinetics similar to that of biochemical DNA double-strand break (DNA-dsb) rejoining. Subnuclear microbeam irradiation studies confirm p53Ser15 is recruited to sites of DNA damage containing gamma-H2AX, ATM(Ser1981), and DNA-PKcs(Thr2609) in vivo. Furthermore, studies using isogenic human and murine cells, which express Ser15 or Ser18 phosphomutant proteins, respectively, show defective nuclear foci formation, decreased induction of p21WAF, decreased gamma-H2AX association, and altered DNA-dsb kinetics following DNA damage. Our results suggest a unique biology for this p53 phosphoform in the initial steps of DNA damage signaling and implicates ATM-p53 chromatin-based interactions as mediators of cell cycle checkpoint control and DNA repair to prevent carcinogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cell Cycle Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Chromatin, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/DNA Repair Enzymes, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Activated Protein Kinase, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/H2AFX protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Histones, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Rad50 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/TP53 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins, http://linkedlifedata.com/resource/pubmed/chemical/ataxia telangiectasia mutated...
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-5472
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
10810-21
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed-meshheading:16322227-Animals, pubmed-meshheading:16322227-Cell Cycle Proteins, pubmed-meshheading:16322227-Cell Nucleus, pubmed-meshheading:16322227-Chromatin, pubmed-meshheading:16322227-DNA, pubmed-meshheading:16322227-DNA Damage, pubmed-meshheading:16322227-DNA Repair, pubmed-meshheading:16322227-DNA Repair Enzymes, pubmed-meshheading:16322227-DNA-Activated Protein Kinase, pubmed-meshheading:16322227-DNA-Binding Proteins, pubmed-meshheading:16322227-Fibroblasts, pubmed-meshheading:16322227-HCT116 Cells, pubmed-meshheading:16322227-Histones, pubmed-meshheading:16322227-Humans, pubmed-meshheading:16322227-Immunoprecipitation, pubmed-meshheading:16322227-Mice, pubmed-meshheading:16322227-Phosphorylation, pubmed-meshheading:16322227-Protein Binding, pubmed-meshheading:16322227-Protein-Serine-Threonine Kinases, pubmed-meshheading:16322227-Signal Transduction, pubmed-meshheading:16322227-Tumor Suppressor Protein p53, pubmed-meshheading:16322227-Tumor Suppressor Proteins
pubmed:year
2005
pubmed:articleTitle
Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo.
pubmed:affiliation
Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Toronto, Canada.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't